Related references
Note: Only part of the references are listed.Recent advances in circulating nucleic acids in oncology
A. Otandault et al.
ANNALS OF ONCOLOGY (2019)
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
Ashton A. Connor et al.
CANCER CELL (2019)
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer
Vincent Bernard et al.
GASTROENTEROLOGY (2019)
Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer
Masayuki Kitano et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary
Claudio Luchini et al.
MODERN PATHOLOGY (2019)
Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy
Wanxia Gai et al.
GENES (2019)
Dissecting the molecular landscape of pancreatic cancer: towards a precision medicine approach
Antonio Pea et al.
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT (2019)
Mutations of key driver genes in colorectal cancer progression and metastasis
Dongdong Huang et al.
CANCER AND METASTASIS REVIEWS (2018)
Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers with or without Liver Metastases
Wanxia Gai et al.
CLINICAL CHEMISTRY (2018)
Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection
Sumbal Sumbal et al.
EXPERIMENTAL HEMATOLOGY (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
KRAS-Mutant non-small cell lung cancer: From biology to therapy
Irene Ferrer et al.
LUNG CANCER (2018)
Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
Davina Gale et al.
PLOS ONE (2018)
Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing
Kun Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Pancreatic cancer circulating tumor cells: applications for personalized oncology
Benjamin J. DiPardo et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
Gahee Park et al.
SCIENTIFIC REPORTS (2018)
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
Chiara Molinari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen et al.
NATURE (2018)
Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Mouliere et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma
Giulio Riva et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis
Maryou B. Lambros et al.
CLINICAL CANCER RESEARCH (2018)
Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status Results of the Prospective CLUSTER Study
Georgios Gemenetzis et al.
ANNALS OF SURGERY (2018)
Clinical Interest of Circulating Tumor DNA in Oncology
Claire Franczak et al.
ARCHIVES OF MEDICAL RESEARCH (2018)
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
Michael J. Pishvaian et al.
ONCOTARGET (2017)
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
Alvin P. Makohon-Moore et al.
NATURE GENETICS (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue
Soichiro Ako et al.
PANCREATOLOGY (2017)
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Joshua D. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
Eveline E. Vietsch et al.
CANCER GENETICS (2017)
Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression
Radim Moravec et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers
Wenshuai Li et al.
CELL RESEARCH (2017)
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
David Sefrioui et al.
BRITISH JOURNAL OF CANCER (2017)
Using circulating cell-free DNA to monitor personalized cancer therapy
Michael Oellerich et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients
K. Allenson et al.
ANNALS OF ONCOLOGY (2017)
Enumeration and Molecular Characterization of Tumor Cells in Lung Cancer Patients Using a Novel In Vivo Device for Capturing Circulating Tumor Cells
Tobias M. Gorges et al.
CLINICAL CANCER RESEARCH (2016)
KRAS mutations in pancreatic circulating tumor cells: a pilot study
Birte Kulemann et al.
TUMOR BIOLOGY (2016)
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
J. S. Ankeny et al.
BRITISH JOURNAL OF CANCER (2016)
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer
Gayatri Premasekharan et al.
CANCER LETTERS (2016)
Detection of KRAS Mutations in Circulating Tumor DNA by Digital PCR in Early Stages of Pancreatic Cancer
Nora Brychta et al.
CLINICAL CHEMISTRY (2016)
Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer
Erina Takai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Pancreatic cancer: Are liquid biopsies ready for prime-time?
Alexandra R. Lewis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control study
Florence Le Calvez-Kelm et al.
ONCOTARGET (2016)
Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Julie Earl et al.
BMC CANCER (2015)
Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer
Hideaki Kinugasa et al.
CANCER (2015)
Genetic analysis of circulating tumor cells in pancreatic cancer patients: A pilot study
Karin Goerner et al.
GENOMICS (2015)
Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas
Oliver A. Zill et al.
CANCER DISCOVERY (2015)
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies
Katarzyna Sikora et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2015)
Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Lesions
Hae Woon Baek et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2015)
Co-amplification at Lower Denaturation-temperature PCR Combined with Unlabled-probe High-resolution Melting to Detect KRAS Codon 12 and 13 Mutations in Plasma-circulating DNA of Pancreatic Adenocarcinoma Cases
Jiong Wu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial
F. C. Bidard et al.
ANNALS OF ONCOLOGY (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
K. C. Allen Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma
Sundeep Singh et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA
Rodolfo Marchese et al.
PANCREAS (2006)
Differential diagnosis between chronic pancreatitis and pancreatic cancer:: value of the detection of KRAS2 mutations in circulating DNA
F Maire et al.
BRITISH JOURNAL OF CANCER (2002)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
